| 000 | 01827 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514022349.0 | ||
| 264 | 0 | _c20020220 | |
| 008 | 200202s 0 0 eng d | ||
| 022 | _a1524-4563 | ||
| 024 | 7 |
_a10.1161/hy1201.097292 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWollert, Kai C | |
| 245 | 0 | 0 |
_aGene transfer of cGMP-dependent protein kinase I enhances the antihypertrophic effects of nitric oxide in cardiomyocytes. _h[electronic resource] |
| 260 |
_bHypertension (Dallas, Tex. : 1979) _cJan 2002 |
||
| 300 |
_a87-92 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aApoptosis _xgenetics |
| 650 | 0 | 4 |
_aCardiomegaly _xdrug therapy |
| 650 | 0 | 4 |
_aCyclic GMP _xanalogs & derivatives |
| 650 | 0 | 4 | _aCyclic GMP-Dependent Protein Kinase Type I |
| 650 | 0 | 4 |
_aCyclic GMP-Dependent Protein Kinases _xbiosynthesis |
| 650 | 0 | 4 | _aDown-Regulation |
| 650 | 0 | 4 | _aDrug Synergism |
| 650 | 0 | 4 | _aGene Transfer Techniques |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMyocardium _xcytology |
| 650 | 0 | 4 |
_aNitric Oxide _xpharmacology |
| 650 | 0 | 4 |
_aNitric Oxide Donors _xpharmacology |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Sprague-Dawley |
| 650 | 0 | 4 |
_aReceptors, Adrenergic, alpha-1 _xphysiology |
| 650 | 0 | 4 |
_aS-Nitroso-N-Acetylpenicillamine _xpharmacology |
| 650 | 0 | 4 |
_aThionucleotides _xpharmacology |
| 700 | 1 | _aFiedler, Beate | |
| 700 | 1 | _aGambaryan, Stepan | |
| 700 | 1 | _aSmolenski, Albert | |
| 700 | 1 | _aHeineke, Jörg | |
| 700 | 1 | _aButt, Elke | |
| 700 | 1 | _aTrautwein, Christian | |
| 700 | 1 | _aLohmann, Suzanne M | |
| 700 | 1 | _aDrexler, Helmut | |
| 773 | 0 |
_tHypertension (Dallas, Tex. : 1979) _gvol. 39 _gno. 1 _gp. 87-92 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1161/hy1201.097292 _zAvailable from publisher's website |
| 999 |
_c11710040 _d11710040 |
||